Market Insights

NBLST CD19 Immune Library: Facilitating Drug Research for B Cell-Related Diseases

NBLST CD19 Immune Library: Facilitating Drug Research for B Cell-Related Diseases

CD19, a type I transmembrane glycoprotein of the immunoglobulin superfamily, is a B cell-specific marker expressed throughout B cell development except plasma cells. It forms a co-receptor complex with CD21/CD81 to augment BCR signaling, activating kinases and downstream molecules, lowering B cell activation threshold and boosting immune sensitivity.
Read More...
Nanobodies reveal the interaction between mGlu2 and TrkB and improve the mechanism of schizophrenia

Nanobodies reveal the interaction between mGlu2 and TrkB and improve the mechanism of schizophrenia

Current schizophrenia drugs mainly block dopamine D2 and 5‑HT receptors, relieving positive symptoms but not negative ones. mGlu2, a GPCR that regulates glutamate transmission, may improve both positive and cognitive symptoms. However, multiple mGlu2‑targeted drugs, including Eli Lilly’s mGlu2/3 agonist pomaglumetad, failed in clinical trials, suggesting a key gap in mechanistic understanding.
Read More...
New Breakthrough in Nanobodies: Precise Regulation of Post-Translational Modifications of Proteins

New Breakthrough in Nanobodies: Precise Regulation of Post-Translational Modifications of Proteins

Protein function relies heavily on post-translational modifications (PTMs), which regulate conformation, activity and interactions. Over 80% of functional proteins undergo reversible PTMs. Palmitoylation, a key PTM, modifies cysteine residues and affects membrane localization and stability. Its abnormality is linked to cancer, neurodegenerative and cardiovascular diseases, yet traditional methods lack spatiotemporal specificity.
Read More...
The precise biological control mechanism for interrupting the transmission of malaria

The precise biological control mechanism for interrupting the transmission of malaria

Malaria is a parasitic disease transmitted by mosquitoes. The 2023 WHO report notes 250 million annual cases and over 600,000 deaths globally, mostly in sub-Saharan Africa. The parasite matures in mosquitoes and infects humans via bites. Its most vulnerable stage is when sporozoites form oocysts. Scientists found the protein PfPIMMS43 helps parasites evade the immune system during this period.
Read More...
The application of nanobodies in autoimmune diseases

The application of nanobodies in autoimmune diseases

Autoimmune diseases occur when the immune system attacks healthy tissues, such as rheumatoid arthritis, lupus, and multiple sclerosis. They are the second most common disorders after cancer and cardiovascular diseases. Their pathogenesis is unclear but linked to genetics, self-antigens, and immune dysregulation. Current treatments like NSAIDs and TNF‑α inhibitors have side effects, and 40% of patients do not respond to TNF‑α inhibitors.
Read More...
Exploring the Unbearable Pain of Life

Exploring the Unbearable Pain of Life

Headache is one of the most common neurological disorders worldwide. Data indicates that approximately 52% of the global population has experienced the affliction of headaches, making it one of the leading causes of disability-adjusted life years (DALYs).
Read More...
When Will There Be a New Way Out for the

When Will There Be a New Way Out for the

Modern society places far higher demands on individuals. High-pressure study/work, complex relationships, and overreliance on electronic devices and virtual worlds reduce real social interaction. Material pursuit further disrupts physical and mental balance, leading to a sharp rise in anxiety and depression compared with previous decades.
Read More...
Can This Virus Actually Have Anti-Cancer Effects?

Can This Virus Actually Have Anti-Cancer Effects?

Approximately 8% of the DNA in the human body is derived from the remnants of retroviruses that infected ancient human ancestors. These retroviruses reverse-transcribed their own RNA into DNA, which integrated into the human genetic material and has been inherited by humans to the present day.
Read More...
Nanobodies May Hold Promise for a Radical Cure of Psoriasis

Nanobodies May Hold Promise for a Radical Cure of Psoriasis

Modern medicine holds that psoriasis is a chronic skin disease caused by multiple factors such as genetic and environmental factors. Similar to lupus erythematosus mentioned earlier in some aspects, it involves immune - mediated factors, which play a crucial role in the occurrence and development of psoriasis.
Read More...